Related by context. All words. (Click for frequent words.) 81 Poster Presentation 76 Abstract Number 76 Late Breaker 75 Poster Discussion 75 Poster Session 74 Oral Session 72 Clinical Trial Results 72 Oral Fingolimod 71 Poster Presentations 71 Podium Presentation 71 Antiviral Therapy 70 Poster Presentation # 70 Relapsing Multiple Sclerosis 69 Neurol 69 Oral Presentations 69 J Clin 69 Suppl. 68 abstr 68 Vitro Activity 68 Abstract # 68 Nephrol 68 Preclinical Data 68 Dendritic Cells 68 Pooled Analysis 68 Placebo Controlled Study 67 Safety Tolerability 67 II Clinical Trial 67 Kinase Inhibitor 67 Double Blind Placebo 67 Nat Clin Pract 67 Dose Ranging Study 67 Proc Am Soc 67 Curr Opin 67 FASEB J. 66 Eur J 66 Castration Resistant Prostate Cancer 66 J Pediatr 66 Orally Active 66 Phase 2b Clinical Trial 66 Prolongs Survival 66 Clin Oncol 66 HCV Protease Inhibitor 66 Meta Analysis 66 Kidney Transplant Recipients 66 Study Evaluating 66 Inflammatory Arthritis 66 Anti Tumor Activity 66 Interv 66 Arch Neurol 66 Clinical Outcome 66 Ophthalmol 66 Tyrosine Kinase Inhibitor 66 J Clin Oncol 66 J Am Soc 66 Phase 2a Trial 66 Oncol 66 Controlled Study 66 LENALIDOMIDE 66 AASLD Meeting 66 Randomized Controlled 66 Controlled Trial 65 Anticancer Drug 65 Phase Ib Clinical Trial 65 Obstet Gynecol 65 J Am Acad 65 Clinical Evaluation 65 Therapeutic Targets 65 Treating Chronic 65 Randomized Double Blind Placebo 65 Novel Inhibitor 65 See CLINICAL PHARMACOLOGY 65 Chronic Hepatitis B 65 J Nutr 65 Cancer Immunotherapy 65 J Child Adolesc 65 Anticancer Activity 65 Anesth 65 Adjuvant Chemotherapy 65 Novel Antibiotic 65 Randomized Phase 65 Preclinical Models 65 Suppl 65 Hemodialysis Patients 65 Thromb Haemost 65 #-# Full Text 65 Hematological Malignancies 65 Psychopharmacol 65 Preclinical Evaluation 65 Chronic Hepatitis C 65 Patients Treated With 65 Antiviral Activity 65 Nicotine Vaccine 65 Meets Primary Endpoint 65 Orthop Surg 65 IND Application 65 Systemic Sclerosis 65 Proteasome 65 Autoimmune Diseases 65 Preclinical Study 65 Phase IIa Clinical Trial 65 Neurosurg 65 Hormone Refractory Prostate Cancer 65 Presents Preclinical Data 64 Drug Candidate 64 Previously Treated 64 Crit Rev 64 Cancer Res 64 Metastatic Melanoma 64 Presents Positive 64 Pharmacodynamics 64 Investigational Drug 64 J Appl 64 Postmenopausal Women 64 Clinical Trial Evaluating 64 Protein Synthesis 64 Adefovir 64 Free Full Text 64 Clinical Efficacy 64 Ann Rheum Dis 64 Endocrinol 64 Multicenter Study 64 Biological Therapy 64 Phase 2b Trial 64 Newly Diagnosed 64 Prenatal Diagnosis 64 Novel Oral 64 #:#-# [023] 64 Phase 2a Clinical Trial 64 Heart Failure Patients 64 J Am Coll 64 Environ Health Perspect 64 Double Blind Randomized 64 Differential Diagnosis 64 #:#-# [031] 64 Arterial Disease 64 Selective Cardiac Myosin 64 Pharmacokinetic Study 64 HDAC Inhibitor 64 Critically Ill Patients 64 Fungal Infections 64 Immunol 64 Novel Therapeutic 64 Vaccine Adjuvant 64 Completes Enrollment 64 Newly Diagnosed Multiple Myeloma 64 Phase IIb Clinical Trial 64 Treated Patients 64 J Allergy Clin 64 Dermatol 64 Chronic Lymphocytic Leukemia 64 Mouse Models 63 Molecular Basis 63 transthyretin TTR mediated amyloidosis 63 Mouse Model 63 J Shoulder Elbow 63 Metastatic Renal Cell Carcinoma 63 Nat Genet 63 Investigational Compound 63 Disease Modifying 63 Pediatr 63 Stent Thrombosis 63 Developmental Therapeutics Immunotherapy 63 Crit Care Med 63 Phase 2b Study 63 Soft Tissue Sarcoma 63 Receptor Antagonist 63 Polymerase Inhibitor 63 Urinary Incontinence 63 #:#-# [037] 63 Improve Survival 63 Slow Progression 63 Demonstrates Positive 63 Soc Sci Med 63 Clinical Trials Update 63 Patients Receiving 63 #:#-# [001] 63 Severe Sepsis 63 Adjuvant Treatment 63 Gastrointestinal Cancers Symposium 63 J Clin Endocrinol Metab 63 Well Tolerated 63 Subgroup Analysis 63 Placebo Controlled Trial 63 Abstract Full Text 63 Pathol 63 Pharmacokinetics PK 63 Int J 63 Am J Clin 63 Receives Orphan Drug Designation 63 Files IND 63 Anticancer Drugs 63 SABCS 63 Rheumatol 63 ANN INTERN MED 63 Completes Patient Enrollment 63 Appears Safe 63 Collaborators Present 63 Tumor Angiogenesis 63 Randomized Double blind 63 Fast Skeletal Troponin 63 Beneficial Effects 63 Novel Therapeutics 63 Psychiatry Clin Neurosci 63 Advanced Solid Tumors 63 Selective Cardiac Myosin Activator 63 Statin Therapy 63 #:#-# [006] 63 Cutaneous T 63 Recombinant Human 63 Modulates 63 Randomized Comparison 63 Osteoporosis Treatment 63 Neoadjuvant Chemotherapy 63 Dose Escalation 63 Relapsed Refractory 62 JAK2 Inhibitor 62 Polymorphism 62 Liver Metastases 62 Nat Rev 62 Bone Metastases 62 ST Segment Elevation 62 Protease Inhibitor 62 Cell Transplant 62 Br J Psychiatry 62 Psychol 62 suppl. 62 Protein Kinase 62 Am J Epidemiol 62 Complicated Skin 62 IN PATIENTS WITH 62 ASCO GI 62 Inflammatory Diseases 62 Patients Undergoing 62 Eur J Cancer 62 Androgen Receptor 62 Phase III Clinical Trial 62 CrossRef Medline 62 Prognostic Significance 62 RNAi Therapeutic 62 J Neurosurg 62 Angiogenic 62 Phase IIb Trial 62 Hsp# Inhibitor 62 #:#-# [033] 62 Immunomodulatory 62 Adjuvant Therapy 62 J Cataract Refract 62 Randomized Controlled Trials 62 Randomized Phase III 62 Plaque Psoriasis 62 #:# -# [005] 62 Antigen Specific 62 Dose Escalation Study 62 Myelodysplastic Syndromes 62 Mol Cell 62 #nd EORTC NCI 62 Anti Tumor 62 Oral Presentation # 62 Am J Obstet 62 Sipuleucel T 62 Hepatic Encephalopathy 62 Neurosci 62 #:#-# [019] 62 Nucleic Acids Res 62 Combination REOLYSIN R 62 Unfractionated Heparin 62 EMBO J. 62 J Foot Ankle 62 Oral Abstract 62 Immune Responses 62 Randomized Double Blind 62 Randomized Trials 62 ST Elevation Acute 62 J Virol 62 Solid Tumors 62 Adjunctive Therapy 62 nd Annual Meeting 62 Cardiotoxicity 62 Abstract Free Full Text 62 Prostate Cancer Symposium 62 Synthetic Peptide 62 Cannabinoid 62 Shows Efficacy 62 Shows Promise Against 62 Demonstrates Significant 62 #th Interscience Conference 62 Hematol 62 Advanced Melanoma 62 Hypertensive Patients 62 Arch Facial Plast 62 Pivotal Phase III 62 Obes Res 62 Sirolimus Eluting Stent 62 Improves Survival 62 Effectively Treats 62 Patients Treated 62 Placebo Controlled 62 Ann Emerg Med 62 Cochrane Database Syst Rev. 62 Unresectable 62 Stent Placement 62 Demonstrates Efficacy 62 Ann Oncol 62 Breast Ultrasound 62 Cardiol 62 Tumor Progression 62 Inhibits 62 Emerging Therapies 62 Toxicol 62 AACR San Antonio 62 Hepatocellular Carcinoma 62 Elderly Patients 62 Initiated Phase 62 #:#-# [025] 62 Prophylactic Treatment 62 J Natl Cancer Inst 62 Cogn 62 Dose Response 62 Small Molecule 62 Diabet Med 61 Refractory Angina 61 Surgical Treatment 61 Br J 61 Arthritis Rheum 61 Announces Poster Presentations 61 J Affect Disord 61 Autoimmune Disease 61 Clin Pharmacol Ther 61 Single Dose 61 J Clin Psychiatry 61 Radiol 61 ASH Annual Meeting 61 Phys Ther 61 Investigational Agent 61 Phase III Trial 61 Child Adolesc Psychiatry 61 Biol 61 Brentuximab Vedotin SGN 61 RNAi Therapeutics 61 Room #B 61 Protein Involved 61 J Urol 61 Intracranial Aneurysms 61 J Consult Clin 61 Hematological 61 Clinical Trial Data 61 Disord 61 IND Filing 61 Crit Care 61 Infected Patients 61 Receptor Antagonists 61 Hepatocellular 61 Randomized Study 61 Advanced Renal Cell 61 Urol 61 Dose Finding 61 Post Operative 61 #:#-# [035] 61 Reperfusion Injury 61 Renal Cancer 61 Antitumor Activity 61 Psychiatric Services #:#-#,# 61 Hedgehog Pathway Inhibitor 61 Trodusquemine MSI 61 Plus Ribavirin 61 Drug Shows Promise 61 Biomarker Study 61 Integrase Inhibitor 61 Mol Psychiatry 61 Parathyroid Hormone 61 Rheumatoid Arthritis Patients 61 Biologic Therapy 61 ERA EDTA 61 Treatment Reduces 61 Breaking Clinical Trials 61 Angiotensin Converting Enzyme 61 Submits NDA 61 Eur Arch 61 Therapy Improves 61 Room #AB [002] 61 #st Annual Meeting 61 Sports Exerc 61 Malignancies 61 Thrombolytic Therapy 61 Advanced Prostate Cancer 61 Initiate Phase 61 Combination Treatment 61 AACR Meeting 61 #:#-# [029] 61 Arch Dermatol 61 Tumor Biology 61 AACR IASLC Joint 61 Initiates Clinical Trial 61 Successfully Completes Phase 61 Biol Psychiatry 61 Ischemic Stroke 61 Oncologic 61 Scand J 61 Thrombotic 61 AAEP Convention 61 Liver Tumors 61 Attenuates 61 doi #.#/fj.#-# 61 Transdermal Delivery 61 Infect Dis 61 Int J Radiat Oncol 61 PMID # [002] 61 Peginterferon 61 Antithrombotic 61 Female Urology 61 Novel Compound 61 Scientific Poster Session 61 Prospective Multicenter 61 #:#-#,# [003] 61 Stent Implantation 61 Granted Orphan Drug 61 Cytotoxicity 61 Forodesine 61 Carotid Stenting 61 Autoimmunity 61 Pharmacother 61 Liposomal 61 Novel Method 61 Treatment Naïve 61 Immunodeficiency 61 doi #.# 61 J Clin Psychopharmacol 61 unfractionated heparin UFH 61 Kinase Inhibitors 61 Randomized Clinical Trial 61 Renal Cell Carcinoma 61 entitled Synergistic 61 Fondaparinux 61 Clin J 61 Dual Antiplatelet Therapy 61 Myoblast 61 Improves Outcomes 61 Rehabil 61 Trial Evaluating 61 AACR #st Annual Meeting 60 Breast Carcinoma 60 Peripheral Arterial 60 ECCMID 60 Eur Respir J 60 Mammalian Cells 60 Metastatic Prostate Cancer 60 Acta Paediatr 60 Vasc 60 Lung Cancer Trial 60 Initiates Phase III 60 Renal Cell Cancer 60 Carnegie Institution Embryology 60 Treatment Naive Patients 60 ASCO Breast Cancer 60 Proves Effective 60 Br J Cancer 60 Immunosuppression 60 BIOCOM Investor Conference 60 Malignant Lymphoma 60 Arch Intern Med 60 Chronic Myeloid Leukemia 60 Therapeutic Potential 60 Cytochrome P# 60 Treatment Naive 60 Thiazolidinediones 60 #:#-# [030] 60 #:#-# [020] 60 Vertebral Fractures 60 Subtypes 60 Present Preclinical Data 60 Immunogenicity 60 Conjugate 60 Aurora Kinase 60 Sleep Disturbances 60 Myelodysplastic Syndrome MDS 60 Breast Cancer Recurrence 60 Test Detects 60 Hematology Annual Meeting 60 Long Term Efficacy 60 Announces Presentation 60 Is Well Tolerated 60 Blood Cancers 60 Inhaled Liposomal Ciprofloxacin 60 Neuromuscular Diseases 60 Laryngeal Cancer 60 Protease Inhibitors 60 HCV Genotype 60 Endocrinol Metab 60 #:# -# [001] 60 Therapy Shows Promise 60 Rotavirus Vaccine 60 Engl J Med 60 J Med 60 Relapsing Remitting Multiple Sclerosis 60 Venous Thromboembolism 60 Br J Haematol 60 Systematic Review 60 Intravenous Formulation 60 Novel Mechanism 60 Inflammatory Markers 60 Immunomedics Announces 60 Solid Malignancies 60 Antiplatelet Therapy 60 Decitabine 60 #:#-# [018] 60 ASCO GU 60 Neural Stem Cells 60 Neoplasia 60 Adjunctive Treatment 60 Brain Metastases 60 Tanespimycin 60 Novel Approaches 60 FDA Approvals 60 Bladder Cancer 60 Arch Dis Child 60 Dose Ranging 60 Psychopharmacol Bull 60 Ovarian Cancer Patients 60 Ocular Diseases 60 Genetic Variation 60 Histone Deacetylase 60 Survival Benefit 60 Tumor Microenvironment 60 Localized Prostate Cancer 60 Pulmonary Arterial Hypertension 60 #:# -# [004] 60 Randomised Controlled Trial 60 Eur Urol 60 Bortezomib 60 Oritavancin 60 Int J Epidemiol 60 Am J Geriatr 60 Shows Promising 60 Neuroendocrine Tumors 60 Recombinant Protein 60 Therapeutics TCT scientific 60 Gram Positive 60 SA FC# 60 Kidney Int 60 ASCO Annual Meeting 60 Murine Model 60 CYP#A# CYP#D# 60 Molecular Mechanisms 60 Acute Heart Failure 60 Study Demonstrates 60 Treatment Experienced 60 Transdermal Patch 60 #:#-# [040] 60 Gynecol Oncol 60 Prostatic 60 Topline Results 60 #:#-# [016] 60 Therapeutic Vaccine 60 Acute Ischemic Stroke 60 Inflammatory Disease 60 Geriatr 60 #nd Annual Meeting 60 Cochrane Database Syst Rev 60 Orthostatic Hypotension 60 Postdoctoral Position 60 Guidelines Recommend 60 Treatment Regimens 60 Pathogenesis 60 Psychiatr 60 Adjunctive 60 Therapeutic Approaches 60 Parenteral Nutrition 60 Progenitor Cells 60 Novel Treatments 60 Innate Immunity 60 ST Elevation Myocardial 60 FRACP 60 Insulin Resistance 60 Inhaled Corticosteroids 60 Hepatitis C Genotype 60 #:#-# [002] 60 Diabetic Nephropathy 60 Am Soc Nephrol 60 Oral Cavity 60 Induction Chemotherapy 60 Replacement Therapy 60 Safinamide 60 Nutr 60 Retrovirus 60 Psychiatric Disorders 60 essential thrombocythemia ET 60 Lowers Risk 60 Therapeutics TCT 60 Diabetic Foot Ulcer 60 Risk Stratification 60 Annual ICAAC 60 Endovascular Repair 60 CARDIOVASCULAR 60 Coronary Interventions 60 Coronary Revascularization 60 FDA Accepts 60 Epidemiol 59 Prospective Randomized 59 J Gerontol 59 Testis 59 Trigeminal Neuralgia 59 Prospective Randomized Trial 59 Biol Phys 59 Allogeneic 59 Systemic Delivery 59 Neuro Oncology SNO 59 Chronic Renal Failure 59 Gastrointestinal Cancer 59 Endometrial Cancer 59 Pharmacyclics Announces 59 Romiplostim 59 Presents Preclinical 59 Annu Rev 59 Viral Infections 59 Randomized Clinical Trials 59 Peginterferon Alfa 2a 59 Adenoma 59 Patients Enrolled 59 Autologous Stem Cell Transplantation 59 Carotid Endarterectomy 59 suppl 59 #:# -# [006] 59 Nilotinib 59 Diagn 59 Hematologic Malignancies 59 Randomized Placebo Controlled Trial 59 Immune Mediated 59 Glatiramer Acetate 59 Stem Cell Transplant 59 Oligonucleotides 59 Clin Endocrinol 59 Tablet Formulation 59 HER2 Positive 59 Developmental Therapeutics 59 FDA Okays 59 Controlled Release 59 familial amyloidotic polyneuropathy FAP 59 Migraine Treatment 59 Febuxostat 59 Cell Lymphoma 59 Prognostic Value 59 Treatment Regimen 59 EMBARGOED UNTIL 59 Am J Respir 59 Molecular Pathogenesis 59 Diabetic Neuropathy 59 Cardiostim 59 Kidney Transplant Patients 59 Pharmacokinetics 59 Left Ventricular Dysfunction 59 First Patient Dosed 59 Gout Drug 59 Bosentan 59 ENDO 59 Ocular Inflammation 59 Gastric Cancer 59 vesicular monoamine transporter 59 AACR NCI EORTC 59 Cardiovascular Outcomes 59 Prevent Stroke 59 PEG IFN 59 Monotherapy 59 Clinical Virology 59 Targeted Therapies 59 First Patient Enrolled 59 Secondary Hyperparathyroidism 59 Neuroprotection 59 #S #S [002] 59 Postmenopausal Osteoporosis 59 Canaccord Adams Hepatitis C 59 CROI 59 Cognitive Problems 59 Help Predict 59 Refractory Hodgkin Lymphoma 59 Renal Transplantation 59 Overactive Bladder 59 Clostridium difficile Infection 59 Circulating Tumor Cells 59 Activator CK # 59 Bosutinib 59 Biotechnol 59 ICAAC IDSA 59 pralatrexate injection folate analogue 59 Ann Intern Med 59 Pediatric Patients 59 Hepatitis C Treatment 59 Gene Linked 59 Proc Natl Acad Sci 59 Multicenter Trial 59 Pemphigus Vulgaris 59 Anticoagulant 59 Physiology Seminar 59 Peer Reviewed Journal 59 Ultrasound Guided 59 Combo Therapy 59 Combination Therapy 59 dual endothelin receptor antagonist 59 Cachexia 59 Successfully Treated 59 Surg 59 Limb Ischemia 59 Hematology Meeting 59 Microbiol 59 Potent Antiviral Activity 59 Abstract P# [002] 59 J Rheumatol 59 Advanced Ovarian Cancer 59 Cardiovasc 59 Intracerebral 59 Gene Variant 59 Chronic Bronchitis 59 Clin Orthop 59 Hypercholesterolemia 59 Arch Pediatr Adolesc Med 59 Schizophr Bull 59 TO AVOID PREGNANCY WHILE 59 Liver Failure 59 Motility 59 Investigational Treatment 59 Slows Progression 59 Inflammatory Pain 59 Long Term Outcomes 59 Myelofibrosis 59 Comput 59 Pivotal Clinical Trial 59 Drug Fails 59 Low Dose 59 lexidronam injection 59 Denufosol 59 Pharmacy OneSource Announces 59 ASCO Abstract 59 Kamada AAT 59 Multiple Myeloma Patients 59 Insulin Therapy 59 Tumor Growth 59 Topical Treatment 59 Spectrum Pharmaceuticals Announces 59 #:#-#,# CrossRef Medline [002] 59 Unstable Angina 59 Previously Untreated 59 Uterine Fibroid Embolization 59 Int J Cancer 59 Lymphocytic 59 Am J Gastroenterol 59 Atypical Hemolytic Uremic Syndrome 59 Tezampanel 59 Phase III Pivotal Trial 59 Reflux Disease 59 Percutaneous Tibial Nerve Stimulation 59 Anti CD# Antibody 59 Int J Obes Relat 59 Gastroenterol 59 Prostate Cancer Vaccine 59 Preterm Labor 59 Skeletal Muscle 59 Immunotherapeutic 59 Immune Cell 59 Teva Provides Update 59 MET VEGFR2 59 Reprod 59 Treatment Outcome 59 Non Alcoholic Steatohepatitis 59 Pulmonary Hypertension 59 Glucosamine Chondroitin Arthritis 59 Enlarged Prostate 59 J Neurol 59 Advanced Colorectal Cancer 59 CT Angiography 59 Drug Eluting 59 AACR symposium 59 Radiofrequency Ablation 59 Chronic Rhinosinusitis 59 J Nerv Ment Dis 59 Romidepsin 59 Immunostimulatory 59 Migraine Drug 59 Chronic Lymphocytic Leukemia CLL 59 Sinus Infections 59 Antifungal 59 Complete Remission 59 Pract 59 SYN# 59 Myeloma Patients 59 Sangamo BioSciences Announces 58 Intracellular 58 Left Ventricular 58 Acute Decompensated Heart Failure 58 Confirmatory Phase 58 Knee Osteoarthritis 58 VASCULAR 58 Malignant Melanoma 58 Expert Opin 58 Neuroprotective Effects 58 Study Showed 58 Antiplatelet 58 J Cardiovasc 58 ScD MPH 58 Cancer Stem Cells 58 Cardiac Stem Cell 58 Initiate Phase III 58 Initiates Enrollment 58 Files Investigational 58 Increased Mortality 58 Cardiac Resynchronization 58 Physiol 58 bone marrow reticulin deposition 58 Eluting Stent 58 #S #S [003] 58 Reduces Mortality 58 Virus Infection 58 Metabolic Disease 58 Non Inferiority 58 Combination Clinical Trial 58 J Biol Chem 58 Am Fam Physician 58 Cell Adhesion 58 J Psychopharmacol 58 Tyrosine Kinase Inhibitors 58 BIO InvestorForum 58 Movement Disorder 58 Guidelines Issued 58 Respiratory Infection 58 Menstrual Pain 58 Mol Biol 58 General Psychiatry #:#-#,# 58 Kidney Function 58 Intravascular 58 Cardiovascular Disease Risk 58 Monoclonal Antibodies 58 Preclinical Studies 58 MEK Inhibitor 58 Hyperlipidemia 58 Gynecol 58 UEGW 58 fosbretabulin 58 Pharmaceuticals Initiates 58 Drug Combo 58 EGFR HER2 58 REG2 58 Int Clin Psychopharmacol 58 Relapsed Multiple Myeloma 58 non nucleoside inhibitor 58 s# s# 58 Nephrol Dial Transplant 58 Non Invasive Treatment 58 Interferon Beta 58 HOLD FOR RELEASE UNTIL 58 Chronic Sinusitis 58 I# I# [002] 58 Multicenter Phase 58 Prostate Cancer Screening 58 Demonstrates Sustained 58 Sustained Efficacy 58 Smooth Muscle 58 Initiates Phase 58 Bare Metal Stent 58 Comorbidities 58 Psychiatry Res 58 Signaling Pathways 58 Hedgehog Pathway 58 Seasonal Influenza Vaccine 58 Synta Announces 58 Coronary Artery 58 Am J Pathol 58 ECNP 58 Diabetic Patients 58 Lung Infections 58 Cancer J Clin 58 Schizophrenia Treatment 58 ACR ARHP 58 R lenalidomide 58 Epithelium 58 VOICE OF THE READER 58 Am J Cardiol 58 Genitourinary Cancers Symposium 58 Ranolazine 58 Sujet du message 58 Lancet Oncol 58 Beta Amyloid 58 Arthritis Drug 58 ISPOR 58 room #AB 58 Newly Diagnosed Patients 58 Protease 58 Pharmacologic 58 Hematological Cancers 58 Br J Dermatol 58 Patients Suffering 58 Respiratory Viruses 58 Sapacitabine 58 st Annual Meeting 58 Significantly Improves 58 Sat/# 58 Prevent Strokes 58 Mg Usa 58 Initiates Clinical 58 Telaprevir VX 58 Nat Med 58 Phase 2a Study 58 Lung Cancer Drug 58 Investigational Oral 58 Respiratory Distress 58 Abstract Accepted 58 Reports Preclinical Data 58 Monoclonal 58 Total Knee Arthroplasty 58 HBeAg + 58 Valopicitabine 58 Novel Therapies 58 CALL FOR ENTRIES 58 Annual Transcatheter Cardiovascular 58 Hormone Receptor Positive 58 Demonstrates Potent 58 Apoptotic 58 Molecular Origins 58 Mycophenolate Mofetil 58 Systemic Lupus Erythematosus 58 #:#-# [007] 58 Fixed Dose 58 Proliferative 58 Minimally Invasive Spine Surgery 58 Chemokine Receptor 58 Skin Lesions 58 Exp Clin 58 Venous Thrombosis 58 Aflibercept 58 Hospital Acquired Pneumonia 58 Telbivudine 58 Anticancer Compound 58 Diabetic Ulcers 58 Cellular Immunology 58 #:#-#,# [002] 58 Mitochondrial Dysfunction 58 Clin Trials 58 Occup 58 Ann Pharmacother 58 Initiates Phase II 58 N Engl J 58 Phase 1b Clinical Trial 58 Molecular Therapeutics 58 Preclinical Efficacy 58 J Cereb Blood 58 Molecular Medicine Tri 58 Premature Infants 58 Benign Prostatic Hyperplasia 58 EULAR Annual 58 S# T# R# 58 Myocardial Ischemia 58 Genes Predict 58 Clin Infect Dis 58 ONGLYZA TM 58 #th Annual Interscience 58 FDA Approves Drug 58 Content Outline 58 Fecal Incontinence 58 Randomized Phase II 58 Cross Malleshwaram 58 Newly Diagnosed Breast Cancer 58 Colorectal Cancer Patients 58 Molecular Targets 58 FDA Clears 58 HER2 Positive Breast Cancer 58 Statistically Significant 58 Glufosfamide 58 Lung Tumors 58 Cognitive Function 58 Artery Disease 58 Osteoarthritis Pain 58 RECORD1 58 Patient Enrollment 58 Cytotoxic T 58 Eye Diseases 58 Anthrax Toxin 58 Predict Risk 58 Osteoporosis Drugs 58 Demonstrate Significant 58 Left Ventricular Hypertrophy 58 Antitumor 58 Anticancer Agent 58 Prognostic Factors 58 Gene Mutation 58 Cardiac Techniques 58 Node Positive 58 PLoS Genet 58 Endarterectomy 58 S1 S# [002] 58 Severe Asthma 58 Hosp Epidemiol 58 Commences Phase 58 Overactive Bladder OAB 58 Clin Chem 58 Blind Placebo Controlled Trial 58 Treating Depression 58 Autoantibodies 58 EORTC NCI AACR 58 Tumor Suppressor Gene 58 Vaccine Adjuvants 58 #:#-# [010] 58 Analogs